Kidney Function after Treatment for Childhood Cancer: A Report from the St. Jude Lifetime Cohort Study
- 2 March 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 32 (4) , 983-993
Abstract
Background Survivors of childhood cancer may be at increased risk for treatment-related kidney dysfunction. Although associations with acute kidney toxicity are well described, evidence informing late kidney sequelae is less robust. Methods To define the prevalence of and risk factors for impaired kidney function among adult survivors of childhood cancer who had been diagnosed ≥10 years earlier, we evaluated kidney function (eGFR and proteinuria). We abstracted information from medical records about exposure to chemotherapeutic agents, surgery, and radiation treatment and evaluated the latter as the percentage of the total kidney volume treated with ≥5 Gy (V5), ≥10 Gy (V10), ≥15 Gy (V15), and ≥20 Gy (V20). We also used multivariable logistic regression models to assess demographic and clinical factors associated with impaired kidney function and Elastic Net to perform model selection for outcomes of kidney function. Results Of the 2753 survivors, 51.3% were men, and 82.5% were non-Hispanic White. Median age at diagnosis was 7.3 years (interquartile range [IQR], 3.3–13.2), and mean age was 31.4 years (IQR, 25.8–37.8) at evaluation. Time from diagnosis was 23.2 years (IQR, 17.6–29.7). Approximately 2.1% had stages 3–5 CKD. Older age at evaluation; grade ≥2 hypertension; increasing cumulative dose of ifosfamide, cisplatin, or carboplatin; treatment ever with a calcineurin inhibitor; and volume of kidney irradiated to ≥5 or ≥10 Gy increased the odds for stages 3–5 CKD. Nephrectomy was significantly associated with stages 3–5 CKD in models for V15 or V20. Conclusions We found that 2.1% of our cohort of childhood cancer survivors had stages 3–5 CKD. These data may inform screening guidelines and new protocol development.Keywords
Funding Information
- National Cancer Institute (CA 21765, CA 195547)
- American Lebanese Syrian Associated Charities
This publication has 42 references indexed in Scilit:
- Long-Term Nephrotoxicity in Adult Survivors of Childhood CancerClinical Journal of the American Society of Nephrology, 2013
- Pilot Induction Regimen Incorporating Pharmacokinetically Guided Topotecan for Treatment of Newly Diagnosed High-Risk Neuroblastoma: A Children's Oncology Group StudyJournal of Clinical Oncology, 2011
- Prospective medical assessment of adults surviving childhood cancer: Study design, cohort characteristics, and feasibility of the St. Jude Lifetime Cohort StudyPediatric Blood & Cancer, 2010
- Validation of Recently Proposed Consensus Criteria for Thrombotic Microangiopathy After Allogeneic Hematopoietic Stem-Cell TransplantationTransplantation, 2010
- Radiation-Associated Kidney InjuryInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: Relevance of age and dose as risk factorsEuropean Journal of Cancer, 2009
- Long-Term Evaluation of Ifosfamide-Related Nephrotoxicity in ChildrenJournal of Clinical Oncology, 2009
- Prospective study on late renal toxicity following postoperative chemoradiotherapy in gastric cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- WT1 and glomerular diseasesPediatric Nephrology, 2006
- A Randomized, Double-Blind Comparative Trial Evaluating the Safety of Liposomal Amphotericin B versus Amphotericin B Lipid Complex in the Empirical Treatment of Febrile NeutropeniaClinical Infectious Diseases, 2000